Linifanib的新应用 申请号：CN201811180198.0 专利类型：发明申请 公开（公告）日：2018-10-10
状态：寻求转化 转让价格：面议
本发明提供一种Linifanib的新应用。Linifanib能够促进白色脂肪细胞褐色化、促进解偶联蛋白1(Ucp1)的表达、促进褐色化标志性基因PrDm16、Pgclα、Cidea、Dio2、Cox8b的mRNA表达水平，同时，能够抑制脂肪前体细胞分化为成熟的脂肪细胞、显著抑制脂肪细胞生成标志性基因Pparγ、Cebpα和Ap2的mRNA表达。可见，Linifanib不仅能促进脂肪细胞褐色化，还能...
Linear actuator asse... 申请号：US15315575 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
A linear actuator system includes a linear actuator and at least one integrated pump assembly connected to the linear actuator to provide fluid to operate the linear actuator. The integrated pump asse...
Linear actuator asse... 申请号：US15517356 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
A linear actuator system includes a linear actuator and at least one proportional control valve and at least one pump connected to the linear actuator to provide fluid to operate the linear actuator. ...
Linear actuator asse... 申请号：US15315575 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
A linear actuator system includes a linear actuator and at least one integrated pump assembly connected to the linear actuator to provide fluid to operate the linear actuator. The integrated pump asse...
Linear actuator asse... 申请号：US15517356 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
A linear actuator system includes a linear actuator and at least one proportional control valve and at least one pump connected to the linear actuator to provide fluid to operate the linear actuator. ...
Linaclotide stable c... 申请号：US15503125 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
A method of stabilizing linaclotide in a solid dosage form, said method comprising a) preparing a composition of linaclotide, acesulfame and pharmaceutically acceptable excipients andb) converting t...
Light member on a pa... 申请号：US15841487 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
Packages that include at least one medicament therein include at least one light member affixed thereto that is capable of emitting light upon activation. The light member is activated upon the openin...
Light member on a pa... 申请号：US15841487 专利类型：发明授权 公开（公告）日：
状态：寻求转化 转让价格：面议
Packages that include at least one medicament therein include at least one light member affixed thereto that is capable of emitting light upon activation. The light member is activated upon the openin...
